Allegretti, J. R., Kelly, C. R., Louie, T., Fisher, M., Hota, S., Misra, B., Van Hise, N. W., Yen, E. F., FACG, , Bullock, J. S., Pullman, J., Nathan, R., Silverman, M., Davis, I., McGill, S., Khanna, S., Pardi, D., Orenstein, R., Grinspan, A., El-Nachef, N., Kraft, C. S., Budree, S., Borody, T. J., & Kassam, Z. (n.d.). s145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection. American journal of gastroenterology, 116, S63–S64. http://access.bl.uk/ark:/81055/vdc_100144524452.0x00004b